Clinical Trial Update: Effect of IFN-γ on Innate Immune Cells [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the effect of interferon-gamma on innate immune cells in chronic granulomatous disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Chronic Granulomatous Disease | Phase 1 | Status: COMPLETED